Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus.

[1]  S. Colan,et al.  Limitations of fractional shortening as an index of contractility in pediatric patients infected with human immunodeficiency virus. , 1994, The Journal of pediatrics.

[2]  R. R. Meyer,et al.  Cardiac mitochondrial DNA polymerase-gamma is inhibited competitively and noncompetitively by phosphorylated zidovudine. , 1994, Circulation research.

[3]  E. Orav,et al.  Cardiac morbidity and related mortality in children with HIV infection. , 1993, JAMA.

[4]  S. De Castro,et al.  Heart involvement in AIDS: a prospective study during various stages of the disease. , 1992, European heart journal.

[5]  S. Colan,et al.  Cardiac structure and function in children with human immunodeficiency virus infection treated with zidovudine. , 1992, The New England journal of medicine.

[6]  S. Colan,et al.  Developmental modulation of myocardial mechanics: age- and growth-related alterations in afterload and contractility. , 1992, Journal of the American College of Cardiology.

[7]  K. Baughman,et al.  Cardiomyopathy Associated with Antiretroviral Therapy in Patients with HIV Infection: A Report of Six Cases , 1992, Annals of Internal Medicine.

[8]  M. Dalakas,et al.  Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[9]  C. Greco,et al.  Prognosis in AZT myopathy , 1991, Neurology.

[10]  W. Grody,et al.  Mitochondrial ultrastructural and molecular changes induced by zidovudine in rat hearts. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[11]  C. Geny,et al.  Zidovudine myopathy: A distinctive disorder associated with mitochondrial dysfunction , 1991, Annals of neurology.

[12]  H. Dittrich,et al.  Reversibility of cardiac abnormalities in human immunodeficiency virus (HIV)-infected individuals: a serial echocardiographic study. , 1991, Journal of the American College of Cardiology.

[13]  S. Dimauro,et al.  Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy , 1991, The Lancet.

[14]  M. Dalakas,et al.  Mitochondrial myopathy caused by long-term zidovudine therapy. , 1990, The New England journal of medicine.

[15]  S. Colan,et al.  Cardiovascular manifestations of human immunodeficiency virus infection in infants and children. , 1989, The American journal of cardiology.

[16]  J. Stewart,et al.  Symptomatic cardiac dysfunction in children with human immunodeficiency virus infection. , 1989, American heart journal.

[17]  P. Albert,et al.  Models for longitudinal data: a generalized estimating equation approach. , 1988, Biometrics.

[18]  J. Marín-García,et al.  Dilated cardiomyopathy in children with acquired immunodeficiency syndrome: a pathologic study of five cases. , 1988, Human pathology.

[19]  S. Zeger,et al.  Longitudinal data analysis using generalized linear models , 1986 .

[20]  K Y Liang,et al.  Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.

[21]  J. Ware,et al.  On the use of repeated measurements in regression analysis with dichotomous responses. , 1979, Biometrics.